Jason Laday

The FDA has approved a supplemental biologics licensing application from Bristol Myers Squibb expanding the indication of abatacept to include children aged 2 years and older with psoriatic arthritis, according to a company press release.“The FDA’s approval of expanding Orencia’s indication adds a much-needed treatment option for children with juvenile psoriatic arthritis, a

SAN DIEGO — Shortness of breath, male sex, age and elevated inflammatory markers are all more predictive of new interstitial lung disease in systemic sclerosis than disease duration, according to data presented at ACR Convergence 2023.“ILD is associated with morbidity and mortality in patients with systemic sclerosis,” Liubov Petelytska, MD, PhD, of University Hospital Zurich,

Oral brepocitinib failed to meet its primary endpoint in a phase 2 trial of adults with moderate to severe lupus, according to a press release from the manufacturer.The study aimed to assess brepocitinib (Priovant Therapeutics) based on the primary endpoint of Systemic Lupus Erythematosus Responder Index change of 4 (SRI-4) at week 52. In a statement, Priovant, which holds the drug’s global

SAN DIEGO — In patients with chronic rheumatic inflammatory disease, those who continue TNF inhibition during pregnancy have similar obstetrical outcomes as those who cease treatment, according to data presented at ACR Convergence 2023.Moreover, pregnant patients who maintained their use of TNF inhibitors experienced fewer severe maternal infections vs. those who stopped, the researchers

The FDA has expanded the approval of an oral liquid methotrexate solution to include children and adolescents with polyarticular juvenile idiopathic arthritis and acute lymphoblastic leukemia, according to a press release.The FDA’s decision marks Jylamvo (methotrexate, Shorla Oncology) as the only oral liquid form of methotrexate approved for both adult and pediatric indications currently

A review of randomized clinical trials published in rheumatology from 2009 to 2023 found that just 39.8% of authors were women, and that women were less likely to be senior authors, according to data published in RMD Open.“In recent years, there has been some progress in narrowing the gender publication gap, but the pace of improvement has shown signs of deceleration, particularly

Healio Rheumatology senior staff writer Rob Volansky has won an APEX Grand Award for Writing/Topics, for the cover story, “‘We cannot pour from an empty cup:’ Work-life balance takes priority for today’s providers.”The Healio Exclusive, available here, appeared in the April 2024 issue of Healio Rheumatology. The APEX Awards for Publication Excellence recognize

AI has within the last few years burgeoned into a ubiquitous presence in physician offices and medical facilities across multiple specialties, including rheumatology.And while its most common uses still appear to be in coding, letter writing and transcribing, AI has also been gaining ground — and utility — at the point of care.

Anodal transcranial direct current stimulation, combined with exercise and patient education, is superior to placebo for improving fibromyalgia pain interference, according to data published in JAMA Network Open.“This study addressed key limitations of previous trials, such as small sample sizes, short follow-up periods, and lack of control for placebo effects,” Wolnei Caumo, MD, PhD,

The 2025 Nobel Prize in Physiology or Medicine has been awarded to a trio of researchers whose work identified and shed light on regulatory T cells and how they prevent the immune system from attacking the body. Mary E. Brunkow, PhD, of the Institute for Systems Biology, in Seattle, Fred Ramsdell, PhD, of Sonoma Biotherapeutics, in San Francisco, and Shimon Sakaguchi, MD, PhD, of Osaka